These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 33218199)
1. Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7. Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199 [TBL] [Abstract][Full Text] [Related]
2. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956 [TBL] [Abstract][Full Text] [Related]
3. Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association. Cheng YM; Tsai CC; Hsu YC Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626412 [TBL] [Abstract][Full Text] [Related]
4. Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells. Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32512849 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800 [TBL] [Abstract][Full Text] [Related]
6. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line. Herman-Antosiewicz A; Xiao H; Lew KL; Singh SV Mol Cancer Ther; 2007 May; 6(5):1673-81. PubMed ID: 17513615 [TBL] [Abstract][Full Text] [Related]
7. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Cho SD; Li G; Hu H; Jiang C; Kang KS; Lee YS; Kim SH; Lu J Nutr Cancer; 2005; 52(2):213-24. PubMed ID: 16201852 [TBL] [Abstract][Full Text] [Related]
8. Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines. Juengel E; Euler S; Maxeiner S; Rutz J; Justin S; Roos F; Khoder W; Nelson K; Bechstein WO; Blaheta RA Phytomedicine; 2017 Apr; 27():1-7. PubMed ID: 28314474 [TBL] [Abstract][Full Text] [Related]
9. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells. Khurana N; Talwar S; Chandra PK; Sharma P; Abdel-Mageed AB; Mondal D; Sikka SC Int J Oncol; 2016 Oct; 49(4):1609-19. PubMed ID: 27499349 [TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway. Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762 [TBL] [Abstract][Full Text] [Related]
11. Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro. Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759798 [TBL] [Abstract][Full Text] [Related]
12. Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells. Tian H; Zhou Y; Yang G; Geng Y; Wu S; Hu Y; Lin K; Wu W Oncol Rep; 2016 Sep; 36(3):1361-8. PubMed ID: 27430422 [TBL] [Abstract][Full Text] [Related]
13. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines. Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818 [TBL] [Abstract][Full Text] [Related]
14. Sulforaphane inhibits proliferation by causing cell cycle arrest at the G2/M phase in rabbit articular chondrocytes. Jeong HJ; Yu SM; Jung JC; Kim SJ Mol Med Rep; 2012 Nov; 6(5):1199-203. PubMed ID: 22941232 [TBL] [Abstract][Full Text] [Related]
15. Expression of cyclin B1, D1 and K in non‑small cell lung cancer H1299 cells following treatment with sulforaphane. Żuryń A; Krajewski A; Klimaszewska-Wiśniewska A; Grzanka A; Grzanka D Oncol Rep; 2019 Feb; 41(2):1313-1323. PubMed ID: 30535470 [TBL] [Abstract][Full Text] [Related]
16. The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line. Żuryń A; Litwiniec A; Safiejko-Mroczka B; Klimaszewska-Wiśniewska A; Gagat M; Krajewski A; Gackowska L; Grzanka D Int J Oncol; 2016 Jun; 48(6):2521-33. PubMed ID: 27035641 [TBL] [Abstract][Full Text] [Related]
17. Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells. Rutz J; Juengel E; Euler S; Maxeiner S; Justin S; Roos F; Chun FK; Blaheta RA Anticancer Res; 2018 Nov; 38(11):6201-6207. PubMed ID: 30396938 [TBL] [Abstract][Full Text] [Related]
18. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity. Jiang LL; Zhou SJ; Zhang XM; Chen HQ; Liu W Biomed Pharmacother; 2016 Mar; 78():74-80. PubMed ID: 26898427 [TBL] [Abstract][Full Text] [Related]
19. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells. Hahm ER; Singh SV Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902 [TBL] [Abstract][Full Text] [Related]
20. p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Shen G; Xu C; Chen C; Hebbar V; Kong AN Cancer Chemother Pharmacol; 2006 Feb; 57(3):317-27. PubMed ID: 16170570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]